Score Breakdown
Offering Ability
46
Cash Runway
40
Float Risk—
Warrant Exposure
40
Convertible Debt
40
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for XTLB.
Market Data
Market Cap$5.77M
Shares Outstanding946.24M
FloatN/A
Cash$259.0K
Debt$86.0K
Short InterestN/A
Institutional Holdings
5 institutional holders · 88.0K shares
#1
Noked Israel Ltd.
49.7K shares
#2
Citadel Advisors Llc
19.0K shares
#3
Smartharvest Portfolios, LLC
13.4K shares
+ 2 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest24.6K
Days to Cover7.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
6-K
8K EVENT
2026-05-07
6-K
8K EVENT
2026-04-29
3
FORM3
2026-03-23
3
FORM3
2026-03-23
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual XTLB Dilution Snapshot
XTL Biopharmaceuticals Ltd. (XTLB) has a DilutionScore of 42/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for XTLB: 6-K on 2026-05-07; 6-K on 2026-04-29; 3 on 2026-03-23.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
📖 Dilution Education
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.